Skip to main content

Peer Review reports

From: Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer

Original Submission
5 Sep 2023 Submitted Original manuscript
10 Oct 2023 Reviewed Reviewer Report
14 Oct 2023 Reviewed Reviewer Report
27 Nov 2023 Author responded Author comments - Bin Wang
Resubmission - Version 2
27 Nov 2023 Submitted Manuscript version 2
6 Dec 2023 Author responded Author comments - Bin Wang
Resubmission - Version 3
6 Dec 2023 Submitted Manuscript version 3
8 Dec 2023 Author responded Author comments - Bin Wang
Resubmission - Version 4
8 Dec 2023 Submitted Manuscript version 4
12 Dec 2023 Author responded Author comments - Bin Wang
Resubmission - Version 5
12 Dec 2023 Submitted Manuscript version 5
15 Dec 2023 Author responded Author comments - Bin Wang
Resubmission - Version 6
15 Dec 2023 Submitted Manuscript version 6
18 Dec 2023 Author responded Author comments - Bin Wang
Resubmission - Version 7
18 Dec 2023 Submitted Manuscript version 7
21 Dec 2023 Reviewed Reviewer Report
30 Dec 2023 Reviewed Reviewer Report
6 Feb 2024 Author responded Author comments - Bin Wang
Resubmission - Version 8
6 Feb 2024 Submitted Manuscript version 8
10 Feb 2024 Author responded Author comments - Bin Wang
Resubmission - Version 9
10 Feb 2024 Submitted Manuscript version 9
Publishing
28 Feb 2024 Editorially accepted
1 Apr 2024 Article published 10.1186/s12890-024-02938-6

You can find further information about peer review here.

Back to article page